---
figid: PMC4966762__13046_2016_401_Fig1_HTML
figlink: /pmc/articles/PMC4966762/figure/Fig1/
number: Fig. 1
caption: Signaling pathways activated by ET-1 in cancer. The endothelin- 1 receptor
  (ET-1R) is a G-protein coupled receptor, that upon agonist binding, results in the
  activation of G-protein-dependent primary effectors including phospholipase Cβ (PLCβ),
  which cleaves phosphatidylinositol- 4,5-bisphosphate (PtdIns(4,5)P2) into diacylglycerol
  (DAG) and inositol triphosphate (IP3), leading to calcium mobilization and protein
  kinase C (PKC) activation, and downstream activation of MAPK family members, including
  ERK1/2. At the same time, ET-1R activation stimulates Ras/Raf/MEK activation, converging
  on ERK1/2 signaling. Moreover, ET-1R receptor stimulation activates phospholipase
  A (PLA) and downstream arachidonic acid (AA) and cyclooxygenase-1 (COX-1) and COX-2,
  leading to prostaglandin E2 (PGE2) release, as well as phosphatidylinositol-3-kinase
  (PI3K), leading to the activation of AKT, integrin-linked kinase (ILK) and glycogen
  synthase kinase (GSK)-3β, which stabilizes β-catenin. Notably, ET-1R can also signal
  via β-arrestin1 (β-arr1) to activate ERK1/2 and PI3K/AKT/β-catenin signaling. β-arr1
  also controls the crosstalk between ET-1R and epidermal growth factor receptor (EGFR)
  through the recruitment and activation of c-Src, resulting in downstream pathway
  activation. Through β-arr1, ET-1 activates also nuclear factor-kB (NF-kB) signaling
  via inhibition of NF-kB inhibitor (IkB), resulting in the dissociation and subsequent
  nuclear localization of active NF-kB. On the other hand, β-arr1 mediates ET-1-induced
  hypoxia-inducible factor 1α (HIF-1α) activity promoting vascular endothelial growth
  factor (VEGF) release. Moreover, ET-1R activates PDZ-RhoGEF leading to Rho-A and
  -C GTPase activation, initiating Rho-dependent signaling events through RHO-associated
  coiled-coil containing protein kinase 1 (ROCK1), LIMK activation, causing cofilin
  inhibition and cytoskeletal remodelling. The cooperation of these intracellular
  signaling pathways promote cell growth, chemoresistance, angiogenesis, cytoskeleton
  remodelling, invadopodia formation, and metastasis
pmcid: PMC4966762
papertitle: β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.
reftext: Laura Rosanò, et al. J Exp Clin Cancer Res. 2016;35:121.
pmc_ranked_result_index: '77164'
pathway_score: 0.9690303
filename: 13046_2016_401_Fig1_HTML.jpg
figtitle: Signaling pathways activated by ET-1 in cancer
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4966762__13046_2016_401_Fig1_HTML.html
  '@type': Dataset
  description: Signaling pathways activated by ET-1 in cancer. The endothelin- 1 receptor
    (ET-1R) is a G-protein coupled receptor, that upon agonist binding, results in
    the activation of G-protein-dependent primary effectors including phospholipase
    Cβ (PLCβ), which cleaves phosphatidylinositol- 4,5-bisphosphate (PtdIns(4,5)P2)
    into diacylglycerol (DAG) and inositol triphosphate (IP3), leading to calcium
    mobilization and protein kinase C (PKC) activation, and downstream activation
    of MAPK family members, including ERK1/2. At the same time, ET-1R activation stimulates
    Ras/Raf/MEK activation, converging on ERK1/2 signaling. Moreover, ET-1R receptor
    stimulation activates phospholipase A (PLA) and downstream arachidonic acid (AA)
    and cyclooxygenase-1 (COX-1) and COX-2, leading to prostaglandin E2 (PGE2) release,
    as well as phosphatidylinositol-3-kinase (PI3K), leading to the activation of
    AKT, integrin-linked kinase (ILK) and glycogen synthase kinase (GSK)-3β, which
    stabilizes β-catenin. Notably, ET-1R can also signal via β-arrestin1 (β-arr1)
    to activate ERK1/2 and PI3K/AKT/β-catenin signaling. β-arr1 also controls the
    crosstalk between ET-1R and epidermal growth factor receptor (EGFR) through the
    recruitment and activation of c-Src, resulting in downstream pathway activation.
    Through β-arr1, ET-1 activates also nuclear factor-kB (NF-kB) signaling via inhibition
    of NF-kB inhibitor (IkB), resulting in the dissociation and subsequent nuclear
    localization of active NF-kB. On the other hand, β-arr1 mediates ET-1-induced
    hypoxia-inducible factor 1α (HIF-1α) activity promoting vascular endothelial growth
    factor (VEGF) release. Moreover, ET-1R activates PDZ-RhoGEF leading to Rho-A and
    -C GTPase activation, initiating Rho-dependent signaling events through RHO-associated
    coiled-coil containing protein kinase 1 (ROCK1), LIMK activation, causing cofilin
    inhibition and cytoskeletal remodelling. The cooperation of these intracellular
    signaling pathways promote cell growth, chemoresistance, angiogenesis, cytoskeleton
    remodelling, invadopodia formation, and metastasis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFC
  - PRKCA
  - NFKB1
  - NFKB2
  - REL
  - PGF
  - VEGFB
  - MAP2K2
  - PRKD3
  - ARAF
  - VEGFA
  - PIK3CG
  - VEGFD
  - RELA
  - RAF1
  - BRAF
  - PIK3R3
  - PRKCZ
  - PLCB1
  - PLCB2
  - HRAS
  - PLCB4
  - PIK3CD
  - AKT2
  - PLCB3
  - PRKCB
  - KRAS
  - RELB
  - CTNNB1
  - SRC
  - EDN1
  - GSK3B
  - ILK
  - LIMK1
  - MAP2K1
  - AKT1
  - PRKCE
  - PRKCG
  - CAT
  - PRKCD
  - PIK3R5
  - PIK3R4
  - PRKCH
  - PIK3R6
  - CFL1
  - CFL2
  - PIK3CA
  - PIK3CB
  - PRKCI
  - PRKCQ
  - RHOC
  - ROCK1
  - AKT3
  - ROCK2
  - MAPK3
  - EGFR
  - NRAS
  - MAPK1
  - DSTN
  - RHOA
  - PGE2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: ET-1
  symbol: ET1
  source: hgnc_alias_symbol
  hgnc_symbol: EDN1
  entrez: '1906'
- word: GSK-3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: ILK
  symbol: ILK
  source: hgnc_symbol
  hgnc_symbol: ILK
  entrez: '3611'
- word: LIMK
  symbol: LIMK
  source: hgnc_alias_symbol
  hgnc_symbol: LIMK1
  entrez: '3984'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: Cat-
  symbol: CAT
  source: hgnc_symbol
  hgnc_symbol: CAT
  entrez: '847'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Cofilin
  symbol: Cofilin
  source: bioentities_symbol
  hgnc_symbol: CFL1
  entrez: '1072'
- word: Cofilin
  symbol: Cofilin
  source: bioentities_symbol
  hgnc_symbol: CFL2
  entrez: '1073'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: RhoA/C
  symbol: RhoC
  source: hgnc_alias_symbol
  hgnc_symbol: RHOC
  entrez: '389'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Cofilin
  symbol: Cofilin
  source: bioentities_symbol
  hgnc_symbol: DSTN
  entrez: '11034'
- word: RhoA/C
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
chemicals:
- word: PGE2
  source: MESH
  identifier: D015232
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
